Boai NKY Medical Holdings Hits Day High with Strong 5.1% Surge

Boai NKY Medical Holdings has experienced a notable increase of 5.1% on May 28, 2026, reaching an intraday high of CNY 18.58. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.12% on the same day. Over the past week, Boai NKY Medical Holdings has shown a solid performance with a 3.42% increase, while its one-month performance reflects a decline of 2.89%. Despite the recent uptick, the company has faced challenges in its long-term growth trajectory. Over the last five years, net sales have grown at an annual rate of 8.82%, and operating profit has increased by 7.19%. However, the company has reported negative results for the last nine consecutive quarters, with net sales for the half-year period at CNY 568.64 million, reflecting a decline of 30.67%. The net profit for the same period was CNY 64.91 million, down 42.19%. With a market capitalization of CNY 5,029 million, Boai NKY Medical Holdings operates within the specialty chemicals industry, characterized by a P/E ratio of 40.00 and a dividend yield of 1.61%.